市场调查报告书
商品编码
1460167
肘部置换市场- 按产品(部分、全部、修订)、材料(不銹钢、钴铬合金、钛合金)、适应症(骨关节炎、类风湿性关节炎、骨折)、最终用途(医院、ASC)-全球预测、 2024 - 2032Elbow Replacement Market - By Product (Partial, Total, Revision), Material (Stainless Steel, Cobalt-Chromium Alloys, Titanium Alloys), Indication (Osteoarthritis, Rheumatoid Arthritis, Fracture), End-use (Hospital, ASC) - Global Forecast, 2024 - 2032 |
由于对微创手术 (MIS) 技术的需求不断增加,2024 年至 2032 年肘关节置换市场规模预计将以 7.4% 的复合CAGR扩大。
最近,患者寻求更短的恢復时间和减少术后疼痛,进一步促使转向微创肘关节置换手术。 MIS 切口更小、组织创伤更少、康復速度更快,吸引了更多人选择肘关节修復。此外,新公司正在向未开发的地区扩张,多家公司正在进军新兴市场,为以前服务不足的地区带来先进的肘部置换技术,进一步加速行业扩张到2032 年。例如,2023 年9 月, Linnaeus 旗下的Wear Referrals 在达勒姆郡成为英国第一个提供来自美国的革命性犬肘置换装置的地方
弯头更换产业分为产品、材料类型、适应症、最终用途和地区。
根据产品,修正弯头更换细分市场的市场规模预计在 2024 年至 2032 年期间将以 6.8% 的成长率成长。修正肘关节置换手术涉及用新的肘关节替换先前植入的义肢肘关节,这通常是由于初次手术引起的磨损、鬆动和併发症。随着人口老化和肘关节衰竭病例的增加,翻修手术的需求不断增加。此外,植入材料、手术技术和假体设计的进步有助于专门解决修復手术的复杂性,以改善结果和患者满意度,从而推动该细分市场的成长。
就最终用途而言,预计到 2032 年,骨科诊所的肘关节置换市场复合CAGR将达到 7.8%。骨科诊所是诊断、治疗和管理肘关节疾病和损伤的重要中心。随着患者对关节炎、骨折和退化性关节疾病的专业护理的偏好不断增加,对肘关节置换手术的需求也增加。这些诊所还提供全面的服务,包括术前评估、术后护理和康復,以满足肘关节置换患者的特定需求。此外,手术技术、植入物设计和患者特异性治疗的进步提高了骨科诊所手术的效率和成功率,进一步推动了产品需求。
从地区来看,2024 年至 2032 年亚太地区弯头置换产业的复合CAGR将达到 8.3%。老年人口的不断增加导致该地区关节炎等疾病的高发生率。医疗服务的普及和持续的研发计划正在推动肘关节置换手术的需求不断增长。例如,2024 年 2 月,全印度医学科学研究所与印度理工学院合作宣布,计划很快开始对印度患者进行肘部置换手术的本土植入物进行临床试验。
此外,随着人们对关节健康的认识不断提高,中国、印度和日本等国家的骨科手术(包括肘关节置换术)数量激增。医疗技术的强劲进步、手术技术的改进以及熟练医疗保健专业人员的存在将促进区域产业的扩张。
Elbow Replacement Market size is set to expand at 7.4% CAGR from 2024 to 2032 owing to the increasing demand for minimally invasive surgery (MIS) techniques.
Of late, patients are seeking shorter recovery times and reduced post-operative pain, further prompting the shift towards less invasive elbow replacement procedures. MIS offers smaller incisions, decreased tissue trauma, and quicker rehabilitation, attracting more individuals to opt for elbow joint restoration. Additionally, new firms are expanding into untapped regions, and multiple companies are venturing into emerging markets for bringing advanced elbow replacement technologies to previously underserved areas, further accelerating the industry expansion through 2032. For instance, in September 2023, Linnaeus-owned Wear Referrals in County Durham emerged as the first in the U.K. to provide a revolutionary canine elbow replacement device from the U.S.
The elbow replacement industry is segmented into product, material type, indication, end-use, and region.
Based on product, the market size from the revision elbow replacement segment is projected to depict 6.8% growth rate from 2024-2032. Revision elbow replacement procedures involve replacing a previously implanted prosthetic elbow joint with a new one, often due to wear, loosening, and complications from the initial surgery. With an aging population and increasing cases of elbow joint failures, the demand for revision surgeries is rising. Moreover, advancements in implant materials, surgical techniques, and prosthetic designs help cater specifically to the complexities of revision procedures for improving outcomes and patient satisfaction, thereby propelling the segment growth.
In terms of end-use, the elbow replacement market from the orthopedic clinics segment is anticipated to attain 7.8% CAGR through 2032. Orthopedic clinics serve as crucial hubs for diagnosing, treating, and managing elbow joint conditions and injuries. With the increasing patient preference for specialized care for arthritis, fractures, and degenerative joint diseases, the demand for elbow replacement surgeries is increasing. These clinics also offer comprehensive services, including pre-surgical evaluations, post-operative care, and rehabilitation for catering to the specific needs of elbow replacement patients. Moreover, advancements in surgical techniques, implant designs, and patient-specific treatments enhance the efficiency and success rates of procedures performed in orthopedic clinics, further boosting the product demand.
Regionally, the Asia Pacific elbow replacement industry is set to exhibit 8.3% CAGR from 2024-2032. The presence of an expanding geriatric population is resulting in a high prevalence of conditions, such as arthritis in the region. The expanding access to healthcare services and the ongoing R&D initiatives are contributing to the growing demand for elbow replacement surgeries. For instance, in February 2024, the All India Institute of Medical Sciences, in partnership with IIT, announced plans to begin clinical trials of indigenous implants for elbow replacement procedures for Indian patients very soon.
Furthermore, countries like China, India, and Japan are witnessing a surge in orthopedic procedures, including elbow replacements, as awareness about joint health is rising. Strong advancements in medical technology, improved surgical techniques, and the presence of skilled healthcare professionals will bolster the regional industry expansion.